
Amgen's Sjögren's Drug Met Its Main Trial Goal. How Well, the Company Has Not Said.
Amgen said on Sept. 22, 2026, that a Phase 3 trial of its experimental drug dazodalibep met its main goal in adults with Sjögren's disease, and did not say by how much. Sjögren's disease is an…










